Mechanical, Aerospace and Nuclear Engineering Department, Rensselaer Polytechnic Institute, Troy, New York 12180, United States.
Langmuir. 2012 Sep 11;28(36):13051-9. doi: 10.1021/la3022479. Epub 2012 Aug 24.
Magnetic iron oxide nanoparticles have numerous applications in the biomedical field, some more mature, such as contrast agents in magnetic resonance imaging (MRI), and some emerging, such as heating agents in hyperthermia for cancer therapy. In all of these applications, the magnetic particles are coated with surfactants and polymers to enhance biocompatibility, prevent agglomeration, and add functionality. However, the coatings may interact with the surface atoms of the magnetic core and form a magnetically disordered layer, reducing the total amount of the magnetic phase, which is the key parameter in many applications. In the current study, amine and carboxyl functionalized and bare iron oxide nanoparticles, all suspended in water, were purchased and characterized. The presence of the coatings in commercial samples was verified with X-ray photoelectron spectroscopy (XPS). The class of iron oxide (magnetite) was verified via Raman spectroscopy and X-ray diffraction. In addition to these, in-house prepared iron oxide nanoparticles coated with oleic acid and suspended in heptane and hexane were also investigated. The saturation magnetization obtained from vibrating sample magnetometry (VSM) measurements was used to determine the effective concentration of magnetic phase in all samples. The Tiron chelation test was then utilized to check the real concentration of the iron oxide in the suspension. The difference between the concentration results from VSM and the Tiron test confirmed the reduction of magnetic phase of magnetic core in the presence of coatings and different suspension media. For the biocompatible coatings, the largest reduction was experienced by amine particles, where the ratio of the effective weight of magnetic phase reported to the real weight was 0.5. Carboxyl-coated samples experienced smaller reduction with a ratio of 0.64. Uncoated sample also exhibits a reduction with a ratio of 0.6. Oleic acid covered samples show a solvent-depended reduction with a ratio of 0.5 in heptane and 0.4 in hexane. The corresponding effective thickness of the nonmagnetic layer between magnetic core and surface coating was calculated by fitting experimentally measured magnetization to the modified Langevin equation.
磁性氧化铁纳米粒子在生物医学领域有许多应用,有些应用已经比较成熟,如磁共振成像(MRI)中的造影剂,有些则还处于新兴阶段,如癌症热疗中的加热剂。在所有这些应用中,磁性粒子都涂有表面活性剂和聚合物,以提高生物相容性、防止团聚并增加功能。然而,这些涂层可能会与磁性核心的表面原子相互作用,形成一个无序的磁性层,从而减少磁性相的总量,这是许多应用中的关键参数。在当前的研究中,购买并表征了胺和羧基功能化的和未涂覆的氧化铁纳米粒子,它们都悬浮在水中。通过 X 射线光电子能谱(XPS)验证了商业样品中涂层的存在。通过拉曼光谱和 X 射线衍射验证了氧化铁的类型(磁铁矿)。除了这些,还研究了用油酸涂覆并悬浮在庚烷和正己烷中的自制氧化铁纳米粒子。从振动样品磁强计(VSM)测量中获得的饱和磁化强度用于确定所有样品中磁性相的有效浓度。然后利用 Tiron 螯合试验来检查悬浮液中氧化铁的实际浓度。VSM 和 Tiron 测试结果之间的浓度差异证实了在涂层和不同悬浮介质存在的情况下,磁性核心的磁性相减少。对于生物相容性涂层,胺颗粒经历了最大的减少,报告的有效磁性相重量与实际重量的比值为 0.5。羧基涂层的样品减少较小,比值为 0.64。未涂覆的样品也表现出减少,比值为 0.6。油酸覆盖的样品在庚烷中表现出溶剂依赖性减少,比值为 0.5,在正己烷中为 0.4。通过将实验测量的磁化率拟合到改进的朗之万方程,计算出磁性核心和表面涂层之间非磁性层的有效厚度。